Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Jaguar Health, Inc. issued an aggregate of approximately 951 shares (the "Preferred Shares") of Series N Perpetual Preferred Stock of preferred stock to certain investors named therein (collectively, the "Purchasers") for aggregate purchase price of approximately $2.38 million.
- Security
- preferred stock
- Shares
- an aggregate of approximately 951 shares (the "Preferred Shares") of Series N Perpetual Preferred Stock
- Purchaser
- certain investors named therein (collectively, the "Purchasers")
- Consideration
- aggregate purchase price of approximately $2.38 million
Exact text from the filing
Shares”) of Series N Perpetual Preferred Stock, par value $0.0001 per share, of the Company (“Series N Preferred Stock”), for an aggregate purchase price of approximately $2.38 million (the “Private Placement”). The Private Placement closed on September 10, 2025, subject to customary closing conditions as set forth in the PIPE Purchase Agreements. The Company
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Jaguar Health, Inc.: Filed Series N Certificate of Designation for preferred stock (effective 2025-09-09).
- Change
- charter amendment
- Effective
- 2025-09-09
Exact text from the filing
Series N Certificate of Designation As disclosed under Items 1.01 and 3.02 above, in connection with the Private Placement, the Company agreed to issue shares of Series N Preferred Stock to the Purchasers. The preferences, rights, limitations and other matters relating to the Series N Preferred Stock are set forth in the Certificate of Designation, which the Company filed with the Secretary of State of the State of Delaware on September 9, 2025.
View on SEC.gov